SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-038098
Filing Date
2019-02-13
Accepted
2019-02-13 16:36:32
Documents
2
Group Members
DANIEL J. BECKERISAAC A. MANKELIAM T. RATCLIFFENEW LEAF BIOPHARMA OPPORTUNITIES II, L.P.NEW LEAF BPO ASSOCIATES II, L.P.NEW LEAF BPO MANAGEMENT II, L.L.C.NEW LEAF VENTURE ASSOCIATES II, L.P.NEW LEAF VENTURE MANAGEMENT II, L.L.C.RONALD M. HUNTVIJAY K. LATH

Document Format Files

Seq Description Document Type Size
1 SC 13G d705205dsc13g.htm SC 13G 218129
2 EX-99.1 d705205dex991.htm EX-99.1 16696
  Complete submission text file 0001193125-19-038098.txt   236803
Mailing Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 (646) 871-6400
New Leaf Ventures II, L.P. (Filed by) CIK: 0001441439 (see all company filings)

IRS No.: 320214549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90643 | Film No.: 19597945
SIC: 2834 Pharmaceutical Preparations